MORGAN STANLEY - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,859,848
-54.0%
890,682
-32.6%
0.00%
-50.0%
Q2 2023$21,413,038
+46.4%
1,320,977
+50.3%
0.00%0.0%
Q1 2023$14,628,873
+168.0%
878,611
+51.3%
0.00%
+100.0%
Q4 2022$5,459,174
+402.7%
580,763
+45.5%
0.00%
Q3 2022$1,086,000
-43.2%
399,241
-39.6%
0.00%
Q2 2022$1,912,000
+78.7%
661,168
+85.5%
0.00%
Q1 2022$1,070,000
+3.5%
356,504
+58.7%
0.00%
Q4 2021$1,034,000
-36.1%
224,643
-12.8%
0.00%
Q3 2021$1,617,000
-39.8%
257,739
-42.5%
0.00%
Q2 2021$2,687,000
+249.0%
448,591
+268.8%
0.00%
Q1 2021$770,000
+58.8%
121,637
+41.3%
0.00%
Q4 2020$485,000
-75.7%
86,079
-74.9%
0.00%
Q3 2020$1,994,000
+63.2%
342,724
+102.3%
0.00%
Q2 2020$1,222,000
+227.6%
169,404
+112.1%
0.00%
Q1 2020$373,000
-79.8%
79,883
-65.3%
0.00%
Q4 2019$1,848,000
+87.2%
230,451
+60.8%
0.00%
Q3 2019$987,000
-4.6%
143,354
+14.9%
0.00%
Q2 2019$1,035,000
-28.2%
124,758
-13.9%
0.00%
Q1 2019$1,441,000
-53.9%
144,932
-64.6%
0.00%
-100.0%
Q4 2018$3,129,000
+13.3%
409,088
+158.0%
0.00%0.0%
Q3 2018$2,762,000
+196.7%
158,550
+61.6%
0.00%
Q2 2018$931,000
+1562.5%
98,136
+661.9%
0.00%
Q1 2018$56,000
+2700.0%
12,881
+1518.2%
0.00%
Q1 2017$2,000
-94.7%
796
-97.5%
0.00%
Q4 2016$38,000
+3700.0%
31,278
+5010.8%
0.00%
Q3 2016$1,0000.0%612
+2.9%
0.00%
Q2 2016$1,000595
+3400.0%
0.00%
Q1 2016$0170.0%0.00%
Q4 2015$017
+6.2%
0.00%
Q2 2015$0160.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders